Intelligence for the Decisions that Matter Most

Pathology's AI platform1 for the experts answering medicine's biggest questions, from discovery through diagnosis.

Clinical LAB SOLUTIONS

At the point of review

An immersive, operationally intelligent review experience for pathology's experts.

CLINICAL
Life Sciences SOLUTIONS

From tissue to treatment

Turn tissue into biomarker insights, move therapies through development and get them to the patients who need them.

LIFE SCIENCES

Trusted by 16 of the top 20 pharma companies
and over 4,000 hospitals and clinics globally.

Bayer logo with green and blue circular swooshes around the name Bayer in dark letters.
Amgen company logo in blue bold uppercase letters.
Unilabs logo with stylized star made of orange and red shapes and red text.
Labcorp logo with blue concentric circles on the left and black text on the right.
Red cursive text spelling Lilly against a transparent background.
Bristol Myers Squibb company logo with purple vertical bar design and bold text.
PathGroup logo with green and black text and slogan Physician Centered. Patient Focused.
Daiichi-Sankyo brand name with a circular blue and green gradient logo
CONCENTRIQ

Pathology AI for
Precision Medicine

The Concentriq¹ portfolio powers precision medicine from discovery through diagnosis, with purpose-built solutions for biomarker research, clinical trials, companion diagnostics, and case review.

Best in KLAS 2026

Concentriq is the highest-rated digital pathology platform in both the United States and Europe. Find out why we’re rated #1 by customers.

Best in KLAS 2026 award badge for Digital Pathology in Europe with an arch illustration.

Trusted at scale. Proven in practice.

12M

cases managed annually by Proscia's customers

4,000+

hospitals and clinics served worldwide

16 of 20

top pharmaceutical companies run on Concentriq

30,000+

studies powered by Concentriq, from discovery to trials

100%

of customers told KLAS they would buy Concentriq again

FEATS OF STRENGTH VIDEO SERIES

The hardest part of going digital isn't the technology.

Behind every successful digital pathology deployment is a pathologist or lab leader who broke down barriers and moved their organization to Pathology AI. Feats of Strength tells their stories.

“Just go ahead and start. It’ll give you something to grow on.”

Dr. Amanda Hemmerich
Global Director of Digital Pathology Innovation
IQVIA Laboratories

"I think the defining moment for me was when I saw that first scanner and saw what it could do. It was like, okay, someday, this is the way we're gonna work.”

Dr. Derrick Forchetti
PathologistSouth Bend Medical Foundation

“In the end we're all doing this for the patient. Whether it's research or education or clinical work, it's all in the end to help the patient get what they need.”

Renee Slaw
Digital Pathology Manager

“I fully believed that this was the right thing to do. And I didn’t waver on that. At the end of the day, we’re doing it for the right reasons, patient care and a better workflow.”

Dr. Sajjad Malik
Medical Director of Digital Pathology
HNL Lab Medicine

¹ The Concentriq portfolio includes distinct configurations. Concentriq AP-Dx is cleared for primary clinical diagnosis. Concentriq AP and Concentriq LS are for Research Use Only; not for use in diagnostic procedures. Proscia’s interoperable AI applications and native AI features are available for research use only on Concentriq AP. In some geographies, certain AI applications may be interoperable with Concentriq AP-Dx. Contact the AI application manufacturers for regulatory authorization status and indications for use. Proscia’s native AI features in Concentriq AP-Dx do not meet the definition of Artificial Intelligence as defined by Regulation (EU) 2024/1689.

Heading